More like $12. $12 is ~5Xsales.
Why pay more for a future low margin product (currently with negative margin)?
The only hope is that when DNDN will have evidence of 12 mo life extension, they might be able to increase the price to $150K/treatment.
Well I dont think DNDN would be well served by getting bought out by a company stupid enough to offer 30.00 for a company selling 6.70 a share... pipe dreams are nice but I hope you aren't basising investments on it .... I we got very lucky the MIGHT get a 15.00 offer , if the pps moves up over 7.50 and stays there. Anything hogher would take a strong advance in DNDN pps